Synergistic effect of cortisol and prostaglandin E2 on the PHA response. Relation to immunosuppression induced by trauma.

PubWeight™: 1.11‹?› | Rank: Top 10%

🔗 View Article (PMC 1540981)

Published in Clin Exp Immunol on December 01, 1976

Authors

M C Berenbaum, W A Cope, R V Bundick

Articles cited by this

Prostaglandins: their disappearance from and release into the circulation. Nature (1967) 8.66

The release and fate of vaso-active hormones in the circulation. Br J Pharmacol (1969) 7.90

The effect of in vivo hydrocortisone on subpopulations of human lymphocytes. J Clin Invest (1974) 4.90

The problem of synergism and antagonism of combined drugs. Arzneimittelforschung (1953) 4.84

Human lymphocytic metabolism. Effects of cyclic and noncyclic nucleotides on stimulation by phytohemagglutinin. J Clin Invest (1971) 3.01

Lymphocyte blast transformation. I. Demonstration of adrenergic receptors in human peripheral lymphocytes. Cell Immunol (1970) 2.58

Postoperative depression of the lymphocyte response to phytohaemagglutinin. Lancet (1967) 2.57

Immunodepression after major surgery in normal patients. Surgery (1975) 2.48

Alternate-day prednisone therapy and human lymphocyte subpopulations. J Clin Invest (1975) 2.10

Radioimmunoassay measurement of prostaglandins E, A, and F in human plasma. J Clin Invest (1973) 2.09

Alterations of the immune response following severe thermal injury. Arch Surg (1966) 2.03

Postoperative depression of tumour-directed cell-mediated immunity in patients with malignant disease. Br Med J (1972) 1.84

Subversion of immune system by tumor cells and role of prostaglandins. Proc Natl Acad Sci U S A (1975) 1.76

Breast cancer, prostaglandins, and bone metastases. Lancet (1975) 1.64

Cellular immunity after intravenous administration of methylprednisolone. J Lab Clin Med (1974) 1.58

Metabolism of prostaglandins A1 and E1 in man. J Clin Invest (1975) 1.50

Delayed hypersensitivity status of burned patients. Surg Forum (1966) 1.33

Prostaglandin-like activity in ocular inflammation. Br Med J (1972) 1.29

Depression of lymphocyte responses after surgical trauma. Br J Exp Pathol (1973) 1.29

Cell-mediated immunity after thermal injury. Ann Surg (1973) 1.24

Enhanced effects of prostaglandin E1 and dibutyryl cyclic AMP upon human lymphocytes in the presence of cortisol. J Clin Invest (1973) 1.18

Immunological studies in burn patients. I. Lymphocyte transformation in vitro. Int Arch Allergy Appl Immunol (1973) 1.09

Plasma catecholamines in severely injured patients: a prospective study on 45 patients with multiple injuries. Br J Surg (1975) 1.01

Prostaglandins in human burn blister fluid. Acta Physiol Scand (1973) 1.00

Effect of surgery on tumour-directed leucocyte responses. Br Med J (1975) 0.99

The immunosuppressive effect of surgery--a possible mechanism. Br J Surg (1973) 0.94

Mixed lymphocyte culture reaction in patients with acute thermal burns. J Trauma (1974) 0.92

Post-operative depression of antibody-dependent lymphocyte cytotoxicity following minor surgery and anaesthesia. Immunology (1976) 0.90

The pattern of aldosterone and cortisone blood levels in thermal burn patients. J Trauma (1974) 0.89

Pituitary-adrenal response to surgical stress in patients receiving corticotrophin treatment. Lancet (1970) 0.87

Lymphocyte response to phytohaemagglutinin following cholecystectomy. Acta Pathol Microbiol Scand (1969) 0.85

Leukocytic response as a monitor of immunodepression in burn patients. Arch Surg (1973) 0.80

Efflux of prostaglandin-like smooth-muscle-stimulating activity in the right lymphatic duct in man. Scand J Clin Lab Invest (1974) 0.78

Effects of intravenous methylprednisolone on mixed lymphocyte cultures in normal humans. Transplant Proc (1975) 0.77

Articles by these authors

A method for testing for synergy with any number of agents. J Infect Dis (1978) 9.52

Is azathioprine a better immunosuppressive than 6-mercaptopurine? Clin Exp Immunol (1971) 3.47

Synergy, additivism and antagonism in immunosuppression. A critical review. Clin Exp Immunol (1977) 2.89

Postoperative depression of the lymphocyte response to phytohaemagglutinin. Lancet (1967) 2.57

Criteria for analyzing interactions between biologically active agents. Adv Cancer Res (1981) 2.49

The expected effect of a combination of agents: the general solution. J Theor Biol (1985) 2.06

In vivo biological activity of the components of haematoporphyrin derivative. Br J Cancer (1982) 1.82

Photodynamic destruction of human bladder carcinoma. Br J Cancer (1975) 1.55

Cerebral photosensitisation by haematoporphyrin derivative. Evidence for an endothelial site of action. Br J Cancer (1986) 1.53

Time-dependent immunosuppressive effects of anti-thymocyte serum. Nature (1967) 1.48

meso-Tetra(hydroxyphenyl)porphyrins, a new class of potent tumour photosensitisers with favourable selectivity. Br J Cancer (1986) 1.47

Dose-response curves for agents that impair cell reproductive integrity. A fundamental difference between dose-response curves of antimetabolites and those for radiation and alkylating agents. Br J Cancer (1969) 1.44

Photodynamic therapy with chlorins for diffuse malignant mesothelioma: initial clinical results. Br J Cancer (1991) 1.42

Cardiac and pulmonary effects of high doses of cyclophosphamide and isophosphamide. Cancer Res (1974) 1.36

Depression of lymphocyte responses after surgical trauma. Br J Exp Pathol (1973) 1.29

Correlations between methods for measurement of synergy. J Infect Dis (1980) 1.29

In vitro lymphocyte response in some immunity deficiency diseases and in intrauterine virus infections. Proc R Soc Med (1970) 1.28

The growth of human tumours in immunosuppressed mice and their response to chemotherapy. Br J Cancer (1974) 1.27

In vivo determination of the fractional kill of human tumor cells by chemotherapeutic agents. Cancer Chemother Rep (1972) 1.26

Cell respiration as a requirement for antibody release in vitro. Nature (1968) 1.21

Hydroporphyrins of the meso-tetra(hydroxyphenyl)porphyrin series as tumour photosensitizers. Biochem J (1989) 1.19

The therapeutic significance of the dose response curve for antilymphocytic serum. Transplantation (1971) 1.02

The effect of microsomal enzyme inhibition on the immunosuppressive and toxic effects of cyclophosphamide. Clin Exp Immunol (1973) 1.01

Immunosuppression by L-asparaginase. Nature (1970) 0.99

The relation between the physico-chemical properties and immunosuppressive effects of an homologous series of sulphonic acid esters. Immunology (1967) 0.97

Synergy with double and triple antibiotic combinations compared. J Antimicrob Chemother (1983) 0.95

Effects of L-asparaginase on lymphocyte-target cell reactions in vitro. Nature (1970) 0.95

Tumour necrosis factor-alpha blockade suppresses murine allergic airways inflammation. Clin Exp Immunol (2007) 0.95

The sensitivity to chemotherapeutic agents of a rat tumour grown in immunosuppressed mice. Br J Cancer (1971) 0.95

Wavelength and light-dose dependence in tumour phototherapy with haematoporphyrin derivative. Br J Cancer (1985) 0.94

Immunosuppressive agents: the design of selective therapeutic schedules. Antibiot Chemother (1969) 0.93

The rabbit VX2 tumour as a model for carcinomas of the tongue and larynx. Acta Otolaryngol (1989) 0.91

Chronic granulomatous disease. Lancet (1969) 0.91

Comparison of the effects of FK-506, cyclosporin A and rapamycin on IL-2 production. Immunology (1991) 0.91

Dissecting the contribution of innate and antigen-specific pathways to the breach of self-tolerance observed in a murine model of arthritis. Ann Rheum Dis (2008) 0.90

Synergy assessment with growth curves. J Infect Dis (1984) 0.90

Leucocyte abnormality in both parents of a patient with chronic granulomatous disease. Lancet (1969) 0.89

Radiosensitivity of immunologically activated cells. Nature (1966) 0.89

Peripheral blood based T cell-containing and T cell-depleted culture systems for human IgE synthesis: the role of T cells. Clin Exp Allergy (1996) 0.88

Minor synergy and antagonism may be clinically important. J Antimicrob Chemother (1987) 0.88

Selective suppression of murine antibody-dependent cell-mediated cytotoxicity by azathioprine. Transplantation (1975) 0.87

HPD - a study of its components and their properties. Adv Exp Med Biol (1983) 0.87

The localization of haemolytic antibody in sections of lymphoid organs: an improved method. Immunology (1970) 0.84

Synergy and antagonism are not synonymous with therapeutic advantage and disadvantage. J Antimicrob Chemother (1988) 0.84

Role of mitosis and mitotic inhibition in the immunosuppressive action of thioguanine. Nature (1966) 0.83

Consequences of synergy between environmental carcinogens. Environ Res (1985) 0.82

Time-dependence and selectivity of immunosuppressive agents. Immunology (1979) 0.82

Protective effects of a novel perfluorochemical emulsion in photodynamic therapy. Biomater Artif Cells Immobilization Biotechnol (1992) 0.82

The effect of cysteine on the immunosuppressive activity of busulphan, cyclophosphamide and nitrogen mustard. Br J Cancer (1971) 0.82

Effect of some metabolic inhibitors on plaque formation in Jerne plates. Nature (1967) 0.81

Effect of cyclophosphamide on the homograft response in the guinea pig. Transplantation (1965) 0.81

Transplantation and immunosuppression. Mod Trends Immunol (1967) 0.81

Re: W. R. Greco et al., Application of a new approach for the quantitation of drug synergism to the combination of cis-diamminedichloroplatinum and 1-beta-D-arabinofuranosylcytosine. Cancer Res., 50: 5318-5327, 1990. Cancer Res (1992) 0.81

Differential asparaginase sensitivity of T-cell and B-cell responses. Clin Exp Immunol (1973) 0.80

The mode of action of cytotoxic drugs. Proc R Soc Med (1970) 0.80

Porphyrin sensitizers in tumour phototherapy. Novel sensitizers of the chlorin and bacteriochlorin class with amphiphilic properties. J Photochem Photobiol B (1990) 0.79

Research ethics and deception. Lancet (1980) 0.78

Letter: Predicting response of human cancer to chemotherapy. Lancet (1974) 0.78

An investigation of the impact of the location and timing of antigen-specific T cell division on airways inflammation. Clin Exp Immunol (2009) 0.78

Immunosuppressive agents: generation and consequences of differing dose-response curves. Proc R Soc Med (1972) 0.78

Chronic relapsing experimental allergic encephalomyelitis. Inhibition of lymphocyte mitogenesis by disease-related serum factors. J Neuroimmunol (1986) 0.78

Immunosuppression by platinum diamines. Br J Cancer (1971) 0.77

Neutrophil function during chemotherapy for Hodgkin's disease. Br J Cancer (1981) 0.77

Cerebrospinal fluid interleukin 1 like activity during chronic relapsing experimental allergic encephalomyelitis. Clin Exp Immunol (1987) 0.77

Photodynamic therapy of a mouse glioma: intracranial tumours are resistant while subcutaneous tumours are sensitive. Br J Cancer (1991) 0.77

Intercellular immunological controls and modulation of cyclic AMP levels. Some doubts. Immunology (1976) 0.77

Concepts for describing the interaction of two agents. Radiat Res (1991) 0.75

Potentiation of in vitro synthesis of human IgE by cyclosporin A (CsA). Clin Exp Immunol (1995) 0.75

Increased therapeutic efficiency of a lipid-soluble alkylating agent incorporated in liposomes. Br J Cancer (1982) 0.75

Modes of action of immunosuppressive agents. Proc R Soc Med (1967) 0.75

Dose-response curves for agents that impair cell reproductive integrity. The relation between dose-response curves and the design of selective regimens in cancer chemotherapy. Br J Cancer (1969) 0.75

Autoimmunity and immunosuppression. Proc R Soc Med (1967) 0.75

Intrathecal interferon, indomethacin, and multiple sclerosis. Lancet (1987) 0.75

The activity of an anti-allergic compound, proxicromil, on models of immunity and inflammation. Agents Actions (1981) 0.75

Effect of L-asparaginase on germinal centre haemolysin. Nature (1971) 0.75

The immunosuppressive effects of 5-fluorocytosine and 5-fluorouracil. Chemotherapy (1979) 0.75

Antagonism between radiosensitizing agents. Br J Radiol (1988) 0.75

Growth of human and rat tumours in immunosuppressed mice. J Pathol (1972) 0.75

Anti-HIV synergy between dextran sulphate and zidovudine. Lancet (1987) 0.75

Subcutaneous Corynebacterium parvum in bladder cancer: a controlled study of its immunological effects. Br J Urol (1979) 0.75

The last surviving cancer cell: the chances of killing it. Cancer Chemother Rep (1968) 0.75

Muscle damage and recovery in the rabbit tongue following photodynamic therapy with haematoporphyrin derivative. Acta Otolaryngol (1991) 0.75